Inovio Pharmaceuticals

Inovio Pharmaceuticals

World Rank (Jan-05-2024)
19,188
Market Cap (Jan-05-2024)
0.156 Billion USD
World Rank (Jul-30-2023)
19,973
Market Cap (Jul-30-2023)
0.138 Billion USD
World Rank (Jan-07-2022)
9,582
Market Cap (Jan-07-2022)
0.970 Billion USD
World Rank (Jan-01-2021)
6,373
Market Cap (Jan-01-2021)
1.515 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
INO
Market Cap (Mar-08-2026)
0.12
Employee Count
317
Employee Count as of Date
As on 2021
Headquarters City/State
Pennsylvania
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1 Million USD
Annual Net Income in USD
-303 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
495 Million USD
Total Liabilities in USD
96 Million USD
Total Equity in USD
399 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Medical Equipment / Instruments
Biotechnology
Company Website
INOVIO PHARMACEUTICALS
Wikipedia
Wikipedia
Yahoo
Yahoo @ Frankfurt
Company Profile
Inovio Pharmaceuticals is a Biotechnology company focused on the discovery and developing precisely designed DNA medicines to potentially treat and protect people from a range of serious and life threatening diseases and infections. The company annual revenue is 4 million USD and 281 employees as on 2019. The headquarters is in USA.
Founded Year
1979
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share